Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pipeline
Biotech
Novartis 'took data to heart' before slimming pipeline by 40%
Novartis slimmed down clinical-stage programs by nearly 40% in recent years as it pharma “took to heart” data showing it wasn’t getting good value.
James Waldron
Nov 21, 2024 5:07am
CSL Behring shuts down California cell and gene therapy R&D site
Nov 18, 2024 8:35am
Omega halts sole clinical-stage asset to focus on 3 programs
Nov 15, 2024 5:33am
Kronos shelves sole clinical drug over neurological side effects
Nov 14, 2024 5:14am
Bayer drops Huntington's gene therapy
Nov 12, 2024 10:09am
ADC Therapeutics axes lead solid tumor drug after phase 1 blow
Nov 7, 2024 8:24am
